{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:08:36Z","timestamp":1788444516554,"version":"build-2803163510"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The gut\u2013liver axis has been increasingly recognized as a major autoimmunity modulator. However, the implications of intestinal barrier in the pathogenesis of autoimmune hepatitis (AIH) remain elusive. Here, we investigated the functional role of gut barrier and intestinal microbiota for hepatic innate immune response in AIH patients and murine models. In this study, we found that AIH patients displayed increased intestinal permeability and pronounced RIP3 activation of liver macrophages. In mice models, intestinal barrier dysfunction increased intestinal bacterial translocation, thus amplifying the hepatic RIP3-mediated innate immune response. Furthermore, GSK872 dampened RIP3 activation and ameliorated the activation and accumulation of liver macrophages <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments. Strikingly, broad-spectrum antibiotic ablation significantly alleviated RIP3 activation and liver injury, highlighting the causal role of intestinal microbiota for disease progression. Our results provided a potentially novel mechanism of immune tolerance breakage in the liver <jats:italic>via<\/jats:italic> the gut-liver axis. In addition, we also explored the therapeutic and research potentials of regulating the intestinal microbiota for the therapy of AIH.<\/jats:p>","DOI":"10.3389\/fimmu.2021.624360","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T05:59:52Z","timestamp":1616651992000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Hongxia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangmao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0588-x","article-title":"The \u201cGut Feeling\u201d: Breaking Down the Role of Gut Microbiome in Multiple Sclerosis","volume":"15","author":"Freedman","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0620-2","article-title":"The human gut microbiome in early-onset type 1 diabetes from the TEDDY study","volume":"562","author":"Vatanen","year":"2018","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The liver as a lymphoid organ","volume":"27","author":"Crispe","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1506330","article-title":"Primary Sclerosing Cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2015.08.012","article-title":"The Gut-Liver Axis in Primary Sclerosing Cholangitis","volume":"20","author":"Eksteen","year":"2016","journal-title":"Clin Liver Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26754","article-title":"Macrophage plasticity and polarization in liver homeostasis and pathology","volume":"59","author":"Sica","year":"2014","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13801","article-title":"Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis","volume":"44","author":"Gr\u00f8nbaek","year":"2016","journal-title":"Aliment Pharm Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26664","article-title":"The role of macrophage migration inhibitory factor in autoimmune liver disease","volume":"59","author":"Assis","year":"2014","journal-title":"Hepatol (Baltimore Md)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4322-z","article-title":"A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients","volume":"61","author":"Assis","year":"2016","journal-title":"Digest Dis Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28676","article-title":"Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury","volume":"64","author":"Roychowdhury","year":"2016","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.12.034","article-title":"Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress","volume":"134","author":"Chenxu","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02985-19","article-title":"RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin","volume":"10","author":"Shrestha","year":"2019","journal-title":"mBio"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/gad.223321.113","article-title":"RIP3: a molecular switch for necrosis and inflammation","volume":"27","author":"Moriwaki","year":"2013","journal-title":"Genes Dev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.569104","article-title":"Bifidobacterium animalis ssp. Lactis 420 mitigates autoimmune hepatitis through regulating intestinal barrier and liver immune cells","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2013.12.013","article-title":"Necrosis-dependent and independent signaling of the RIP kinases in inflammation","volume":"25","author":"Moriwaki","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-immunol-032414-112248","article-title":"Programmed necrosis in the cross talk of cell death and inflammation","volume":"33","author":"Chan","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2018.05.008","article-title":"Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex","volume":"92","author":"Rizzetto","year":"2018","journal-title":"J\u00a0Autoimmun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214514","article-title":"Prevotella copri in individuals at risk for rheumatoid arthritis","volume":"78","author":"Alpizar-Rodriguez","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31311","article-title":"The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications","volume":"72","author":"Dean","year":"2020","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40168-017-0359-2","article-title":"Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease","volume":"5","author":"Dubinkina","year":"2017","journal-title":"Microbiome"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"14","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: a therapeutic target","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20150744","article-title":"Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset","volume":"213","author":"Costa","year":"2016","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.3390\/ijms20194871","article-title":"Recent Advances in Our Understanding of the Link between the Intestinal Microbiota and Systemic Lupus Erythematosus","volume":"20","author":"Kim","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3390\/jcm8111770","article-title":"An Association of Gut Microbiota with Different Phenotypes in Chinese Patients with Rheumatoid Arthritis","volume":"8","author":"Chiang","year":"2019","journal-title":"J Clin Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814558116","article-title":"Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes","volume":"116","author":"Sorini","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8291-x","article-title":"Leaky gut and autoimmune diseases","volume":"42","author":"Fasano","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.1038\/s41598-018-27615-7","article-title":"Liver X receptors regulate hepatic F4\/80 (+) CD11b(+) Kupffer cells\/macrophages and innate immune responses in mice","volume":"8","author":"Endo-Umeda","year":"2018","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-015-0609-3","article-title":"RIP1 Inhibition Rescues from LPS-Induced RIP3-Mediated Programmed Cell Death, Distributed Energy Metabolism and Spatial Memory Impairment","volume":"57","author":"Nikseresht","year":"2015","journal-title":"J Mol Neurosci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155723","article-title":"Receptor Interacting Protein 3-Mediated Necroptosis Promotes Lipopolysaccharide-Induced Inflammation and Acute Respiratory Distress Syndrome in Mice","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900752R","article-title":"RIP3 deficiency alleviates liver fibrosis by inhibiting ROCK1-TLR4-NF-kappaB pathway in macrophages","volume":"33","author":"Wei","year":"2019","journal-title":"FASEB J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101387","article-title":"Receptor interacting protein kinase 3 (RIP3) regulates iPSCs generation through modulating cell cycle progression genes","volume":"35","author":"Al-Moujahed","year":"2019","journal-title":"Stem Cell Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nature10273","article-title":"FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation","volume":"477","author":"Welz","year":"2011","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats","volume":"180","author":"Taurog","year":"1994","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i42.9257","article-title":"Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis","volume":"22","author":"Czaja","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-immunol-070119-115104","article-title":"Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine","volume":"38","author":"Kayama","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.chom.2020.07.014","article-title":"Programing of an Intravascular Immune Firewall by the Gut Microbiota Protects against Pathogen Dissemination during Infection","volume":"28","author":"McDonald","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.020","article-title":"The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation","volume":"66","author":"Schrumpf","year":"2017","journal-title":"J Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.624360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T05:59:54Z","timestamp":1616651994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.624360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2021.624360"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.624360","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"article-number":"624360"}}